Detalhe da pesquisa
1.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883228
2.
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
Microb Pathog
; 167: 105562, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513293
3.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitol Res
; 120(12): 4037-4047, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664113
4.
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Cytokine
; 129: 155031, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062145
5.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485231
6.
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection.
Vaccines (Basel)
; 10(7)2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891310
7.
Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins.
Vet Parasitol
; 296: 109513, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225189
8.
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
Immunol Lett
; 220: 11-20, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981576